ROSA DAVID A (CEO and President) reported 1 transaction at NEUROONE MEDICAL TECHNOLOGIES CORP
Review the transaction codes below to understand the nature of each event.
Filed: 1/3/2025ACC: 0001213900-25-000714
DirectorOfficer· CEO and President
Since Feb 2026
-4.70K
Net shares
Net seller
$3.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.70K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.70K
Price / share
$0.83
Trade value
$3.88K
% of position
0.4%
12/31/2024
1.14M→1.14M
Total
Net shares
−4.70K
Net value
-$3.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2024 | F · Tax Withholding | −4.70K | $0.83 | $3.88K | 0.4% | 1.14M | 1.14M |
| Total | −4.70K | -$3.88K | ||||||
Derivative Transactions0
No derivative transactions reported